Skip to main content
. 2021 Jan;10(1):104–116. doi: 10.21037/tlcr-20-888

Table 1. Patient characteristics with lung adenocarcinoma.

Characteristics Values
No. of patients 20
Median age, years (range) 68 (42 to 88)
Sex
   Male 8 (40%)
   Female 12 (60%)
Smoking status
   NS 14 (70%)
   EX 2 (10%)
   CS 4 (20%)
T_stage
   1 5 (25%)
   2 5 (25%)
   3 2 (10%)
   4 8 (40%)
N_stage
   0 4 (20%)
   1 2 (10%)
   2 4 (20%)
   3 10 (50%)
M_stage
   0 8 (40%)
   1 12 (60%)
AJCC_stage
   IA 1 (5%)
   IIIA 3 (15%)
   IIIB 4 (20%)
   IV 12 (60%)
BALF EGFR genotype
   19del 12 (60%)
   19del and T790M 1 (5%)
   L858R 5 (25%)
   G719C/S768I 1 (5%)
   T790M (de novo) 1 (5%)
Tissue type
  Surgical 4 (20%)
  Biopsy 16 (80%)
BALF cytology
  Atypical cells 1 (5%)
  Positive 9 (45%)
  Negative 10 (50%)
Tumor location
  Border 2 (10%)
  Peripheral 8 (40%)
  Central 10 (50%)
Histologic subtype, surgical case
  Acinar 90% lepidic 10% 2
  Acinar 30% lepidic 70% 1
  Acinar 60% solid 40% 1
Spread through air spaces (STAS), surgical case
  Positive 2
  Tumor size (cm) 3.5±1.4

NS, non-smoker; EX, ex-smoker; CS, current smoker.